Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 932 results for "usfda"

USFDA registration: India agri exports under threat
CommodityOnline

USFDA registration: India agri exports under threat

MUMBAI(Commodity Online): The US Food and Drug Administration (USFDA) has issued a warning that India's agri export consignments will be held at the US port if the exporters fail to register with the administration by December 31. Many of the ... CommodityOnline, 21 hours ago
US FDA warns Indian agri-exporters Business Standard, 2 days ago

25 images for usfda

India TV, 1 week ago
Financial Express, 1 week ago
CommodityOnline, 20 hours ago
CommodityOnline, 20 hours ago
CommodityOnline, 20 hours ago
CommodityOnline, 20 hours ago
Business Standard India, 1 day ago
Millennium Post, 3 days ago
Business Today India, 1 week ago
Business Today India, 2 weeks ago

IPA, Pharmexcil organises technical conference

The theme for the conference was USFDA- Steps for Sustained Compliance The Indian Pharmaceutical Association (IPA), Industrial Pharmacy Division, jointly with IPA MP State Branch and Pharmaceuticals Export Promotion Council of India (Pharmexcil) ...
 Financial Express12 hours ago

Dr Reddy's Lab's Visakhapatnam unit comes under USFDA lens

USFDA is conducting a surprise inspection of Dr Reddy's Laboratories Visakhapatnam plant. The US Food and Drug Administration (USFDA) is conducting a surprise inspection of Dr Reddy's Laboratories Visakhapatnam plant. The inspection, which ...
 Financial Express1 day ago Dr Reddy's Laboratories rallies over 6%, hits 52-week high on USFDA approval  Economic Times2 weeks ago Dr Reddy's jumps 5%  India Infoline2 weeks ago

Ranbaxy fails to block rivals in generic fight

Indian drugmaker Ranbaxy, which was out to fight with the USFDA over withdrawing tentative approvals for two drugs, has faced a blow as a US district judge denied the company's request to not allow other generic makers enter the market. Ranbaxy in ...
 Financial Chronicle1 day ago RANBAXY LABORATORIES : Ghosts of slip ups past: usfda withdraws approvals for two ranbaxy generics  4 Traders1 week ago GHOSTS OF SLIP UPS PAST: USFDA WITHDRAWS APPROVALS FOR TWO RANBAXY GENERICS  Pharmacy Choice1 week ago
Millennium Post

Ranbaxy shares slump 5%; mcap down Rs 1,072 crore

Laboratories slumped nearly 5 per cent today as the company sued USFDA over revoking an approval to sell generic versions of two drugs -- digestive disorder medicine Nexium and anti-viral Valcyte-- in the US market. Also, the drug maker is being moved out of ...
 Business Standard2 days ago Ranbaxy Laboratories files complaint against USFDA for revoking approved drugs  Indian-Commodity2 days ago Ranbaxy files suit against USFDA for revoking approved drugs  DNA3 days ago Ranbaxy sues USFDA  The Statesman3 days ago
[x]  
Rediff.com

USFDA issues warning against Cadila Pharmaceuticals

The significant violations included the failure of the company to adequately probe or take corrective action after customer complaints between 2011 and 2012 about unpleasant odours from, and impurities in, certain drug batches sold in the US, the USFDA said. The US Food and Drug Administration has issued a warning letter to Ahmedabad-based Cadila Pharmaceuticals for violating current good manufacturing practice norms at its Ankleshwar plant in Gujarat. In a warning letter, USFDA said inspectors ...
 Rediff.com1 week ago USFDA issues warning letter to Cadila Pharmaceuticals  Business Standard1 week ago Cadila Pharma falls on warning letter from USFDA  Business Standard1 week ago US FDA sends warning letter to Cadila Pharma  India Infoline1 week ago
[x]  
Business Standard India

USFDA surprise inspection at Dr Reddy's Vizag unit

The FDA has been tightening its monitoring of Indian pharma majors over compliance issues. Surprise plant inspections and import alerts have been frequent outcomes Digbijay Mishra | New Delhi November 20, 2014 Last Updated at 00:50 IST Related News ...
 Business Standard India2 days ago USFDA bans two Indian plants on GMP violations  Money Control1 month ago No USFDA import alert on Sun's Halol plant, shares up 6%  Business Standard1 month ago USFDA continues to audit Sun Pharma's Halol plant  Money Control2 months ago
[x]  

Ranbaxy Lab drops after reports of suing USFDA for revoking drug approvals

Ranbaxy Laboratories declined 2.03% to Rs 629.10 at 15:25 IST on BSE on reports company has sued the US Food and Drug Administration for revoking approvals granted to the firm to launch copies of two drugs. Meanwhile, the S&P BSE Sensex was down 24.44 points ...
 Business Standard3 days ago
Business Today India

US sales of Indian drug firms hit by delay in FDA approvals

Domestic drug firms expect a slowdown in new generic drug approvals by the United States Food and Drug Administration (USFDA) to weigh on sales in their largest market for at least two more quarters, due to an ongoing overhaul of the review process.
 Business Today India1 week ago USFDA accepts filing of NDA for empagliflozin/metformin FDC  PharmaBiz1 month ago Indian drug firms see fall in US sales on FDA approval delays  Indian Mirror1 week ago Drugmakers see US sales hit by delay in new approvals  Economic Times1 week ago
India TV

USFDA warns Cadila Pharma over drug production processes

Cadila Pharmaceuticals is the latest Indian drugmaker to face U.S. regulatory rebuke, as the FDA intensifies its scrutiny of the generic drugmakers.
 Economic Times1 week ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - usfda
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less